Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 2
1983 3
1984 2
1985 2
1986 1
1987 4
1988 3
1989 2
1991 2
1992 2
1993 1
1994 1
1995 2
1996 4
1997 1
1998 1
1999 7
2000 6
2001 8
2002 7
2003 4
2004 8
2005 7
2006 7
2007 6
2008 5
2009 5
2012 1
2013 1
2018 1
2019 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 10524687

109 results

Results by year

Filters applied: . Clear all
Page 1
The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial.
Felson DT, LaValley MP, Baldassare AR, Block JA, Caldwell JR, Cannon GW, Deal C, Evans S, Fleischmann R, Gendreau RM, Harris ER, Matteson EL, Roth SH, Schumacher HR, Weisman MH, Furst DE. Felson DT, et al. Arthritis Rheum. 1999 Oct;42(10):2153-9. doi: 10.1002/1529-0131(199910)42:10<2153::AID-ANR16>3.0.CO;2-W. Arthritis Rheum. 1999. PMID: 10524687 Free article. Clinical Trial.
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V. Cohen S, et al. Arthritis Rheum. 2001 Sep;44(9):1984-92. doi: 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B. Arthritis Rheum. 2001. PMID: 11592358 Free article. Clinical Trial.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Free article. Clinical Trial.
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, Cheung N, Williams B, Hazleman B, Price R, Yoshizaki K, Nishimoto N, Kishimoto T, Panayi GS. Choy EH, et al. Arthritis Rheum. 2002 Dec;46(12):3143-50. doi: 10.1002/art.10623. Arthritis Rheum. 2002. PMID: 12483717 Free article. Clinical Trial.
Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO 3rd, Li J, Louie J, Furst DE. Weinblatt ME, et al. Arthritis Rheum. 2008 Jul;58(7):1921-30. doi: 10.1002/art.23493. Arthritis Rheum. 2008. PMID: 18576334 Free article. Clinical Trial.
109 results